Does the media refer more to MED or BHST?

In the previous week, Medifast had 1 more articles in the media than BioHarvest Sciences. MarketBeat recorded 4 mentions for Medifast and 3 mentions for BioHarvest Sciences. BioHarvest Sciences' average media sentiment score of 0.76 beat Medifast's score of 0.57 indicating that BioHarvest Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medifast 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioHarvest Sciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, WALD or BHST?

BioHarvest Sciences has lower revenue, but higher earnings than Waldencast. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waldencast $272.07M 0.41 -$229.75M N/A N/A BioHarvest Sciences $34.51M 1.03 -$11.14M -$0.52 N/A

Does the media refer more to BHST or FTLF?

In the previous week, FitLife Brands had 1 more articles in the media than BioHarvest Sciences. MarketBeat recorded 4 mentions for FitLife Brands and 3 mentions for BioHarvest Sciences. FitLife Brands' average media sentiment score of 0.96 beat BioHarvest Sciences' score of 0.76 indicating that FitLife Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioHarvest Sciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FitLife Brands 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor LFVN or BHST?

In the previous week, BioHarvest Sciences had 1 more articles in the media than Lifevantage. MarketBeat recorded 3 mentions for BioHarvest Sciences and 2 mentions for Lifevantage. Lifevantage's average media sentiment score of 0.91 beat BioHarvest Sciences' score of 0.76 indicating that Lifevantage is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifevantage 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioHarvest Sciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend SLSN or BHST?

BioHarvest Sciences has a consensus price target of $6.50, suggesting a potential upside of 257.14%. Given BioHarvest Sciences' stronger consensus rating and higher possible upside, analysts plainly believe BioHarvest Sciences is more favorable than Solesence. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solesence 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BioHarvest Sciences 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media favor SLSN or BHST?

In the previous week, BioHarvest Sciences had 1 more articles in the media than Solesence. MarketBeat recorded 3 mentions for BioHarvest Sciences and 2 mentions for Solesence. BioHarvest Sciences' average media sentiment score of 0.76 beat Solesence's score of 0.54 indicating that BioHarvest Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solesence 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive BioHarvest Sciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

BioHarvest Sciences (BHST) Competitors

$1.74 -0.08 (-4.12%)

Closing price 03:55 PM Eastern

Extended Trading

$1.71 -0.04 (-2.01%)

As of 06:34 PM Eastern

Compare

BHST vs. MED, WALD, FTLF, LFVN, and SLSN

Should you buy BioHarvest Sciences stock or one of its competitors? BioHarvest Sciences's main competitors and comparable companies include Medifast (MED), Waldencast (WALD), FitLife Brands (FTLF), Lifevantage (LFVN), and Solesence (SLSN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does BioHarvest Sciences compare to Medifast?

Medifast (NYSE:MED) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

Medifast has a net margin of -8.08% compared to BioHarvest Sciences' net margin of -31.21%. Medifast's return on equity of -6.69% beat BioHarvest Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medifast	-8.08%	-6.69%	-5.25%
BioHarvest Sciences	-31.21%	-58.30%	-25.60%

BioHarvest Sciences has lower revenue, but higher earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than BioHarvest Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medifast	$385.79M	0.34	-$18.67M	-$2.33	N/A
BioHarvest Sciences	$34.51M	1.03	-$11.14M	-$0.52	N/A

Medifast has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market. Comparatively, BioHarvest Sciences has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market.

95.5% of Medifast shares are owned by institutional investors. 3.7% of Medifast shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Medifast had 1 more articles in the media than BioHarvest Sciences. MarketBeat recorded 4 mentions for Medifast and 3 mentions for BioHarvest Sciences. BioHarvest Sciences' average media sentiment score of 0.76 beat Medifast's score of 0.57 indicating that BioHarvest Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medifast	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BioHarvest Sciences	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medifast currently has a consensus price target of $12.00, indicating a potential upside of 2.54%. BioHarvest Sciences has a consensus price target of $6.50, indicating a potential upside of 257.14%. Given BioHarvest Sciences' stronger consensus rating and higher possible upside, analysts plainly believe BioHarvest Sciences is more favorable than Medifast.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medifast	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
BioHarvest Sciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

BioHarvest Sciences beats Medifast on 8 of the 15 factors compared between the two stocks.

How does BioHarvest Sciences compare to Waldencast?

Waldencast (NASDAQ:WALD) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

Waldencast has a net margin of 0.00% compared to BioHarvest Sciences' net margin of -31.21%. Waldencast's return on equity of 0.00% beat BioHarvest Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waldencast	N/A	N/A	N/A
BioHarvest Sciences	-31.21%	-58.30%	-25.60%

BioHarvest Sciences has lower revenue, but higher earnings than Waldencast.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waldencast	$272.07M	0.41	-$229.75M	N/A	N/A
BioHarvest Sciences	$34.51M	1.03	-$11.14M	-$0.52	N/A

42.0% of Waldencast shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, BioHarvest Sciences had 2 more articles in the media than Waldencast. MarketBeat recorded 3 mentions for BioHarvest Sciences and 1 mentions for Waldencast. Waldencast's average media sentiment score of 1.82 beat BioHarvest Sciences' score of 0.76 indicating that Waldencast is being referred to more favorably in the media.

Company	Overall Sentiment
Waldencast	Very Positive
BioHarvest Sciences	Positive

Waldencast presently has a consensus target price of $2.33, suggesting a potential upside of 168.51%. BioHarvest Sciences has a consensus target price of $6.50, suggesting a potential upside of 257.14%. Given BioHarvest Sciences' stronger consensus rating and higher possible upside, analysts plainly believe BioHarvest Sciences is more favorable than Waldencast.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waldencast	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
BioHarvest Sciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Waldencast has a beta of -0.1, meaning that its stock price is 110% less volatile than the broader market. Comparatively, BioHarvest Sciences has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market.

Summary

Waldencast and BioHarvest Sciences tied by winning 6 of the 12 factors compared between the two stocks.

How does BioHarvest Sciences compare to FitLife Brands?

BioHarvest Sciences (NASDAQ:BHST) and FitLife Brands (NASDAQ:FTLF) are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

BioHarvest Sciences has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market. Comparatively, FitLife Brands has a beta of 0.06, meaning that its share price is 94% less volatile than the broader market.

In the previous week, FitLife Brands had 1 more articles in the media than BioHarvest Sciences. MarketBeat recorded 4 mentions for FitLife Brands and 3 mentions for BioHarvest Sciences. FitLife Brands' average media sentiment score of 0.96 beat BioHarvest Sciences' score of 0.76 indicating that FitLife Brands is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioHarvest Sciences	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
FitLife Brands	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

FitLife Brands has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioHarvest Sciences	$34.51M	1.03	-$11.14M	-$0.52	N/A
FitLife Brands	$81.46M	1.05	$6.33M	$0.62	14.63

BioHarvest Sciences currently has a consensus target price of $6.50, indicating a potential upside of 257.14%. FitLife Brands has a consensus target price of $18.00, indicating a potential upside of 98.46%. Given BioHarvest Sciences' higher possible upside, research analysts plainly believe BioHarvest Sciences is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioHarvest Sciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
FitLife Brands	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

2.3% of FitLife Brands shares are owned by institutional investors. 61.7% of FitLife Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

FitLife Brands has a net margin of 6.15% compared to BioHarvest Sciences' net margin of -31.21%. FitLife Brands' return on equity of 18.10% beat BioHarvest Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioHarvest Sciences	-31.21%	-58.30%	-25.60%
FitLife Brands	6.15%	18.10%	7.63%

Summary

FitLife Brands beats BioHarvest Sciences on 14 of the 17 factors compared between the two stocks.

How does BioHarvest Sciences compare to Lifevantage?

Lifevantage (NASDAQ:LFVN) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk and analyst recommendations.

In the previous week, BioHarvest Sciences had 1 more articles in the media than Lifevantage. MarketBeat recorded 3 mentions for BioHarvest Sciences and 2 mentions for Lifevantage. Lifevantage's average media sentiment score of 0.91 beat BioHarvest Sciences' score of 0.76 indicating that Lifevantage is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lifevantage	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BioHarvest Sciences	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Lifevantage currently has a consensus price target of $5.50, suggesting a potential downside of 7.56%. BioHarvest Sciences has a consensus price target of $6.50, suggesting a potential upside of 257.14%. Given BioHarvest Sciences' stronger consensus rating and higher probable upside, analysts plainly believe BioHarvest Sciences is more favorable than Lifevantage.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifevantage	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
BioHarvest Sciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

35.3% of Lifevantage shares are held by institutional investors. 13.6% of Lifevantage shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Lifevantage has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market. Comparatively, BioHarvest Sciences has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market.

Lifevantage has a net margin of 2.78% compared to BioHarvest Sciences' net margin of -31.21%. Lifevantage's return on equity of 21.56% beat BioHarvest Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifevantage	2.78%	21.56%	11.62%
BioHarvest Sciences	-31.21%	-58.30%	-25.60%

Lifevantage has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifevantage	$182.59M	0.41	$5.07M	$0.40	14.88
BioHarvest Sciences	$34.51M	1.03	-$11.14M	-$0.52	N/A

Summary

Lifevantage beats BioHarvest Sciences on 10 of the 16 factors compared between the two stocks.

How does BioHarvest Sciences compare to Solesence?

Solesence (NASDAQ:SLSN) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

Solesence has a beta of 1.37, suggesting that its share price is 37% more volatile than the broader market. Comparatively, BioHarvest Sciences has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market.

BioHarvest Sciences has a consensus price target of $6.50, suggesting a potential upside of 257.14%. Given BioHarvest Sciences' stronger consensus rating and higher possible upside, analysts plainly believe BioHarvest Sciences is more favorable than Solesence.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solesence	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BioHarvest Sciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Solesence has higher revenue and earnings than BioHarvest Sciences. Solesence is trading at a lower price-to-earnings ratio than BioHarvest Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solesence	$62.06M	1.13	$1.79M	-$0.03	N/A
BioHarvest Sciences	$34.51M	1.03	-$11.14M	-$0.52	N/A

Solesence has a net margin of -3.40% compared to BioHarvest Sciences' net margin of -31.21%. Solesence's return on equity of -11.58% beat BioHarvest Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solesence	-3.40%	-11.58%	-3.79%
BioHarvest Sciences	-31.21%	-58.30%	-25.60%

70.2% of Solesence shares are owned by institutional investors. 4.8% of Solesence shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, BioHarvest Sciences had 1 more articles in the media than Solesence. MarketBeat recorded 3 mentions for BioHarvest Sciences and 2 mentions for Solesence. BioHarvest Sciences' average media sentiment score of 0.76 beat Solesence's score of 0.54 indicating that BioHarvest Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solesence	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
BioHarvest Sciences	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Solesence beats BioHarvest Sciences on 10 of the 15 factors compared between the two stocks.

Get BioHarvest Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BHST vs. The Competition

Export

Metric	BioHarvest Sciences	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$34.24M	$23.92B	$16.31B	$12.93B
Dividend Yield	N/A	5.37%	3.29%	22.89%
P/E Ratio	-3.36	22.22	13.96	25.30
Price / Sales	0.99	13.37	264,297.16	76.39
Price / Cash	N/A	26.71	57.21	53.04
Price / Book	1.34	3.48	4.45	5.92
Net Income	-$11.14M	$1.13B	$844.17M	$381.04M
7 Day Performance	17.11%	-0.01%	0.87%	-4.39%
1 Month Performance	-3.06%	-6.00%	-2.51%	-7.26%
1 Year Performance	-85.49%	-21.10%	9.66%	-4.95%

BioHarvest Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BHST BioHarvest Sciences	3.2318 of 5 stars	$1.75 -4.1%	$6.50 +272.5%	-85.4%	$34.24M	$34.51M	N/A	89	News Coverage
MED Medifast	1.9829 of 5 stars	$11.61 +1.6%	$12.00 +3.4%	-11.8%	$129.81M	$385.79M	N/A	380	News Coverage Short Interest Decrease
WALD Waldencast	2.3425 of 5 stars	$0.87 -1.2%	$2.33 +168.5%	-53.8%	$111.75M	$272.07M	N/A	367	Positive News Gap Up
FTLF FitLife Brands	4.8392 of 5 stars	$9.21 +5.9%	$18.00 +95.4%	-55.0%	$86.49M	$81.46M	14.76	81	Gap Down
LFVN Lifevantage	2.352 of 5 stars	$6.00 +0.2%	$5.50 -8.3%	-34.3%	$75.53M	$182.59M	15.00	223	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BHST) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BioHarvest Sciences (BHST) Competitors

BHST vs. MED, WALD, FTLF, LFVN, and SLSN

How does BioHarvest Sciences compare to Medifast?

Summary

How does BioHarvest Sciences compare to Waldencast?

Summary

How does BioHarvest Sciences compare to FitLife Brands?

Summary

How does BioHarvest Sciences compare to Lifevantage?

Summary

How does BioHarvest Sciences compare to Solesence?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHST vs. The Competition

BioHarvest Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BioHarvest Sciences (BHST) Competitors

BHST vs. MED, WALD, FTLF, LFVN, and SLSN

How does BioHarvest Sciences compare to Medifast?

Is MED or BHST more profitable?

Which has preferable earnings & valuation, MED or BHST?

Which has more volatility and risk, MED or BHST?

Do insiders & institutionals have more ownership in MED or BHST?

Does the media refer more to MED or BHST?

Do analysts rate MED or BHST?

Summary

How does BioHarvest Sciences compare to Waldencast?

Is WALD or BHST more profitable?

Which has better valuation and earnings, WALD or BHST?

Do insiders and institutionals believe in WALD or BHST?

Does the media refer more to WALD or BHST?

Do analysts rate WALD or BHST?

Which has more volatility & risk, WALD or BHST?

Summary

How does BioHarvest Sciences compare to FitLife Brands?

Which has more volatility and risk, BHST or FTLF?

Does the media refer more to BHST or FTLF?

Which has preferable valuation and earnings, BHST or FTLF?

Do analysts rate BHST or FTLF?

Do insiders & institutionals have more ownership in BHST or FTLF?

Is BHST or FTLF more profitable?

Summary

How does BioHarvest Sciences compare to Lifevantage?

Does the media favor LFVN or BHST?

Do analysts rate LFVN or BHST?

Do insiders and institutionals hold more shares of LFVN or BHST?

Which has more risk & volatility, LFVN or BHST?

Is LFVN or BHST more profitable?

Which has higher valuation & earnings, LFVN or BHST?

Summary

How does BioHarvest Sciences compare to Solesence?

Which has more volatility and risk, SLSN or BHST?

Do analysts recommend SLSN or BHST?

Which has stronger valuation and earnings, SLSN or BHST?

Is SLSN or BHST more profitable?

Do institutionals and insiders hold more shares of SLSN or BHST?

Does the media favor SLSN or BHST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHST vs. The Competition

BioHarvest Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools